CCR2 and visceral leishmaniasis: In a visceral leishmaniasis study using L. donovani, Ly6Chi inflammatory monocytes formed an important niche for parasite survival, and blocking their recruitment to the liver and spleen using CCR2 antagonists reduced bacterial burdens (Terrazas et al., 2017).